Form 4: Hims & Hers CMO Carroll Reports RSU Vesting, Tax Withholding

Hims & Hers Health, Inc. Chief Medical Officer Patrick Harrison Carroll reported the vesting of 16,522 restricted stock units and the withholding of 4,022 shares for tax obligations.

Summary

• Patrick Harrison Carroll, Chief Medical Officer and Director of Hims & Hers Health, Inc., reported transactions on March 13, 2026.
• Acquired 16,522 shares of Class A Common Stock through the vesting and settlement of Restricted Stock Units (RSUs).
• Disposed of 4,022 shares of Class A Common Stock at a price of $24.77 per share.
• These disposed shares were withheld by the issuer to cover tax withholding obligations related to the RSU vesting.
• Following these transactions, Carroll directly beneficially owns 182,440 shares of Class A Common Stock.
• The RSU vesting involved three separate grants with different vesting schedules, all converting on March 13, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. While shares were disposed for taxes, the underlying RSU vesting indicates continued executive compensation and a significant remaining stake, aligning executive interests with shareholders.

Positives

• Executive Patrick Harrison Carroll continues to hold a significant number of shares (182,440 Class A Common Stock) directly, indicating alignment with shareholder interests.
• The vesting of Restricted Stock Units (RSUs) represents a planned compensation event, reflecting the executive's continued service to the company.

Negatives

• 4,022 shares of Class A Common Stock were disposed of to cover tax withholding obligations, which is a common practice but reduces the executive's direct ownership slightly.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transaction filings like Form 4 are routine disclosures and typically do not reflect broader industry trends. This specific filing details a standard executive compensation event (RSU vesting) and associated tax withholding, which is common across publicly traded companies.

Stakeholder Impact

• Shareholders: The transactions are routine and reflect standard executive compensation. The executive maintains a substantial direct ownership, which generally aligns management interests with shareholders.
• Employees: The RSU vesting demonstrates the company's compensation structure for executives, which can influence broader employee compensation strategies.

Next Steps

• Remaining 24,446 Restricted Stock Units (from the first grant) will continue to vest in substantially equal quarterly installments on March 15, June 15, September 15, and December 15.
• Remaining 38,717 Restricted Stock Units (from the second grant) will continue to vest in substantially equal quarterly installments on March 15, June 15, September 15, and December 15.
• Remaining 42,397 Restricted Stock Units (from the third grant) will continue to vest in substantially equal quarterly installments on March 15, June 15, September 15, and December 15.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of restricted stock units and the subsequent sale of shares to cover tax obligations. Such events are standard executive compensation practices and do not typically indicate a change in the company's fundamental outlook or the executive's long-term commitment. The executive retains a significant direct ownership stake. Therefore, the filing itself does not provide new information warranting a change in investment posture, suggesting a 'hold' recommendation based solely on this disclosure.

Keywords

Hims & Hers Health, HIMS, Patrick Harrison Carroll, Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Stock Ownership, Executive Compensation, Tax Withholding